Howard Colman

University of Utah

Full Professor(heuristic)

Glioma Diagnosis and Treatment · Genetics

Compare more Genetics professors.

h-index71
i10-index149
Publications409
Citations44,830

Grants

1 total · 1 active

NIH #R01CA300362

Effects of combined FAK inhibition with MAPK blockade in brain metastases from cutaneous melanoma

Active
Amount
$600K–$700K
Period
2026-04-01 → 2031-03-31
PIs
2

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

1 total · 1 active

NIH #R01CA300362

Effects of combined FAK inhibition with MAPK blockade in brain metastases from cutaneous melanoma

Active
Amount
$600K–$700K
Period
2026-04-01 → 2031-03-31
PIs
2

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

Recent Public Signals

  1. New paper: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial (Journal of Clinical Oncology)2026-04-14
  2. New NIH award: Effects of combined FAK inhibition with MAPK blockade in brain metastases from cutaneous melanoma2026-04-01
  3. New preprint: Comprehensive analysis of TEAD inhibition in meningioma identifies MEK and mTOR inhibition as effective combination therapies against resistant lines2026-03-24

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-26

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0002-4027-7317

Professor Insights

Career Trajectory